Literature DB >> 1693458

Immunotherapy for infectious diseases.

J E Pennington1.   

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Homer A. Boushey, MD, Professor of Medicine, and Nathan M. Bass, MD, PhD, Associate Professor of Medicine, under the direction of Lloyd H. Smith, Jr, MD, Professor of Medicine and Associate Dean in the School of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693458      PMCID: PMC1002359     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  26 in total

1.  Intravenous administration of human gamma-globulin.

Authors:  S BARANDUN; P KISTLER; F JEUNET; H ISLIKER
Journal:  Vox Sang       Date:  1962       Impact factor: 2.144

2.  Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.

Authors:  D R Snydman; B G Werner; B Heinze-Lacey; V P Berardi; N L Tilney; R L Kirkman; E L Milford; S I Cho; H L Bush; A S Levey
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

3.  Bacterial infections in human immunodeficiency virus-infected children.

Authors:  K Krasinski; W Borkowsky; S Bonk; R Lawrence; S Chandwani
Journal:  Pediatr Infect Dis J       Date:  1988-05       Impact factor: 2.129

4.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

5.  Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation.

Authors:  R A Bowden; M Sayers; N Flournoy; B Newton; M Banaji; E D Thomas; J D Meyers
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

6.  Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants.

Authors:  E C Reed; R A Bowden; P S Dandliker; K E Lilleby; J D Meyers
Journal:  Ann Intern Med       Date:  1988-11-15       Impact factor: 25.391

7.  Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.

Authors:  E Girardin; G E Grau; J M Dayer; P Roux-Lombard; P H Lambert
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

8.  Intravenous immune globulin in symptomatic paediatric human immunodeficiency virus infection.

Authors:  U B Schaad; A Gianella-Borradori; B Perret; P Imbach; A Morell
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

9.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

10.  Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency.

Authors:  J Björkander; C Cunningham-Rundles; P Lundin; R Olsson; R Söderström; L A Hanson
Journal:  Am J Med       Date:  1988-01       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.